Top-News

Immunomedics News

Keine aktuellen Kursdaten verfügbar
WKN: 872983
ISIN: US4529071080
US-Symbol: IMMU
Typ: Aktie

Immunomedics News

05.10.20 - PR Newswire
ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm - CBMG, VRTU, MR, IMMU, JCAP
ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm - CBMG, VRTU, MR, IMMU, JCAP PR Newswire
02.10.20 - PR Newswire
WeissLaw LLP Reminds MR, IMMU, and BMCH Shareholders About Its Ongoing Investigations
WeissLaw LLP Reminds MR, IMMU, and BMCH Shareholders About Its Ongoing Investigations PR Newswire
25.09.20 - PR Newswire
WeissLaw LLP Reminds MR, IMMU, and BMCH Shareholders About Its Ongoing Investigations
WeissLaw LLP Reminds MR, IMMU, and BMCH Shareholders About Its Ongoing Investigations PR Newswire
25.09.20 - PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds AKCA, IMMU, and MXIM Shareholders About Its Ongoing Investigations
SHAREHOLDER ALERT: WeissLaw LLP Reminds AKCA, IMMU, and MXIM Shareholders About Its Ongoing Investigations PR Newswire
16.09.20 - The Motley Fool
2 positive Nachrichten für und wie die Gilead Sciences-Aktie bewertet ist!
Gilead Sciences (WKN: 885823) war einer der ersten Konzerne, der ein wirksames Mittel gegen COVID-19 zu besitzen schien. Dabei hatte das Unternehmen keinen speziellen ...
15.09.20 - PR Newswire
Moore Kuehn Encourages IMMU, ONDK, VRTU, and OTEL Investors to Contact Law Firm
Moore Kuehn Encourages IMMU, ONDK, VRTU, and OTEL Investors to Contact Law Firm PR Newswire
15.09.20 - PR Newswire
ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm
ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm PR Newswire
14.09.20 - PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Investigates Immunomedics, Inc.
SHAREHOLDER ALERT: WeissLaw LLP Investigates Immunomedics, Inc. PR Newswire
14.09.20 - Der Aktionär
Gilead schlägt schon wieder zu – Milliarden‑Übernahme!
14.09.20 - dpa-AFX
Gilead will Biotech-Firma Immunomedics kaufen - mehr als 100 Prozent Aufschlag
Der Pharmakonzern Gilead Sciences will sich mit dem Kauf des Biotech-​Unternehmens Immunomedics bei Krebstherapien verstärken. Dafür legt Gilead rund 21 Milliarden US-...
20.08.20 - PR Newswire
(IMMU) Alert: Shareholder Class Action Against Immunomedics Survives Motion to Dismiss; Should Management be Held Accountable for Investors Losses? Contact Johnson Fistel
(IMMU) Alert: Shareholder Class Action Against Immunomedics Survives Motion to Dismiss; Should Management be Held Accountable for Investors Losses? Contact Johnson Fistel ...
09.07.20 - PR Newswire
Lifshitz Law Firm, P.C. Announces Investigation of Acer Therapeutics, Inc. (ACER), Advanced Disposal Services, Inc. (ADSW), Apyx Medical Corporation (APYX), Honeywell International Inc. (HON), Immunomedics, Inc. (IMMU), National General Holdings Corp. (NGHC) and Zuora, Inc. (ZUO)
Lifshitz Law Firm, P.C. Announces Investigation of Acer Therapeutics, Inc. (ACER), Advanced Disposal Services, Inc. (ADSW), Apyx Medical Corporation (APYX), Honeywell ...
23.04.20 - PR Newswire
Thinking about buying stock in Chesapeake Energy Corp, General Electric, Immunomedics, TOP Ships, or United Airlines?
Thinking about buying stock in Chesapeake Energy Corp, General Electric, Immunomedics, TOP Ships, or United Airlines? PR Newswire
30.01.19 - PR Newswire
Scott+Scott Attorneys at Law LLP Reminds Investors of Securities Class Action Against Immunomedics, Inc.
Scott+Scott Attorneys at Law LLP Reminds Investors of Securities Class Action Against Immunomedics, Inc. PR Newswire
30.01.19 - PR Newswire
IMMUNOMEDICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Immunomedics, Inc. To Contact The Firm
IMMUNOMEDICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Immunomedics, Inc. To Contact The Firm PR ...
25.01.19 - PR Newswire
IMMUNOMEDICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Immunomedics, Inc. - IMMU
IMMUNOMEDICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against ...
25.01.19 - PR Newswire
IMMU CLASS ACTION: Rosen Law Firm Announces Securities Class Action Lawsuit Against Immunomedics, Inc. - IMMU
IMMU CLASS ACTION: Rosen Law Firm Announces Securities Class Action Lawsuit Against Immunomedics, Inc. - IMMU PR Newswire
12.01.19 - PR Newswire
Johnson Fistel, LLP Notifies Investors of Class Actions Against Sogou Inc., Immunomedics, Inc., and Ternium S.A.; Investors Encouraged to Contact Firm
Johnson Fistel, LLP Notifies Investors of Class Actions Against Sogou Inc., Immunomedics, Inc., and Ternium S.A.; Investors Encouraged to Contact Firm PR Newswire
11.01.19 - PR Newswire
RM LAW Announces Class Action Lawsuit Against Immunomedics, Inc.
RM LAW Announces Class Action Lawsuit Against Immunomedics, Inc. PR Newswire
08.01.19 - PR Newswire
Investor Alert: Kaplan Fox Announces Investigation Of Immunomedics, Inc.
Investor Alert: Kaplan Fox Announces Investigation Of Immunomedics, Inc. PR Newswire

Newssuche

Videos

newspaper
18.04.24 +2,17%
Technical Trading: Gold mit weiterem Potenzial
Gold Long Typ: Turbo Open End WKN: UH4MU6 Hebel: 4,67 Laufzeit: OpenEnd Einstieg: Market ... Mehr »